Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133896) titled 'Real-world study of the effectiveness and tolerability of outpatient titration of OxyContin for the moderate and severe pain in cancer patients' on Oct. 9.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Cancer Hospital Chinese Academy of Medical Sciences
Condition:
Moderate to severe cancer pain (NRS >= 4)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-13
Target Sample Size: Treatment group (Exposure group):378;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=345765
Disclaimer: Curated by...